Lanean...
Extracellularly activatable nanocarriers for drug delivery to tumors
INTRODUCTION: Nanoparticles for drug delivery to tumors need to satisfy two seemingly conflicting requirements: they should maintain physical and chemical stability during circulation and be able to interact with target cells and release drug at desired locations with no substantial delay. Unique mi...
Gorde:
| Argitaratua izan da: | Expert Opin Drug Deliv |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4292874/ https://ncbi.nlm.nih.gov/pubmed/24950343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/17425247.2014.930434 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|